tiprankstipranks
Integra Lifesciences Holdings Corp. (IART)
NASDAQ:IART
US Market

Integra Lifesciences (IART) Financial Statements

Compare
240 Followers

Integra Lifesciences Financial Overview

Integra Lifesciences's market cap is currently $1.69B. The company's EPS TTM is $-0.09; its P/E ratio is ―; Integra Lifesciences is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $0.43. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 1.61B$ 1.54B$ 1.56B$ 1.54B$ 1.37B
Gross Profit$ 882.06M$ 888.39M$ 970.31M$ 944.64M$ 851.03M
Operating Income$ 28.41M$ 111.53M$ 238.92M$ 197.23M$ 151.37M
EBITDA$ 193.29M$ 274.01M$ 391.10M$ 366.33M$ 267.93M
Net Income$ -6.94M$ 67.74M$ 180.55M$ 169.07M$ 133.89M
Balance Sheet
Cash & Short-Term Investments$ 273.57M$ 309.10M$ 456.66M$ 513.45M$ 470.17M
Total Assets$ 4.04B$ 3.78B$ 3.89B$ 3.78B$ 3.62B
Total Debt$ 215.38M$ 1.68B$ 1.62B$ 1.65B$ 1.66B
Net Debt$ -31.00M$ 1.41B$ 1.16B$ 1.14B$ 1.19B
Total Liabilities$ 2.49B$ 2.19B$ 2.09B$ 2.10B$ 2.10B
Stockholders' Equity$ 1.55B$ 1.59B$ 1.80B$ 1.68B$ 1.51B
Cash Flow
Free Cash Flow$ 24.96M$ 73.09M$ 217.38M$ 264.35M$ 139.94M
Operating Cash Flow$ 129.38M$ 139.96M$ 264.47M$ 312.43M$ 203.83M
Investing Cash Flow$ -390.81M$ -94.18M$ -58.58M$ -161.44M$ -68.07M
Financing Cash Flow$ 237.86M$ -229.93M$ -251.95M$ -98.23M$ 121.63M
Currency in USD

Integra Lifesciences Earnings and Revenue History

Integra Lifesciences Debt to Assets

Integra Lifesciences Cash Flow

Integra Lifesciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis